Analystreport

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at Goldman Sachs Group, Inc. (The) from a "neutral" rating to a "buy" rating.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview